Episode 211: 211. Pharmacogenomics Testing, PHASER,
Questioning Medicine12 Jul 2023

Episode 211: 211. Pharmacogenomics Testing, PHASER,


(https://www.healthquality.va.gov/guidelines/MH/mdd/VADoDMDDCPGFinal508.pdf) clearly state there is insufficient evidence to support this activity and testing. This is mainly because of low quality evidence and concern of bias given commercially funded studies.

(https://www.aafp.org/pubs/afp/issues/2023/0100/poems-pharmacogenic-testing-antidepressants.html)

American Psychiatric Association Psychiatry.org - Genetic Testing to Improve Psychiatric Medication Choice

Harvard https://www.health.harvard.edu/blog/gene-testing-to-guide-antidepressant-treatment-has-its-time-arrived-2019100917964

First prime


As I mention in my response email PRIME the primary outcomes per clinnicaltrials.gov were depression remission at 24 weeks, which was not statically significant. And then a use of fewer medications that have a potential gene-drug interaction which from what I can find was a ‘theoretical’ interaction not an actual increase in adverse events. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial | Depressive Disorders | JAMA | JAMA Network




“The PREPARE Study

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113234/#:~:text=Open%2Dlabel%20placebo%20reduced%20minimum,0.02%25%20in%20the%20TAU%20arm. When patients were told they were getting placebo for back pain and it helped their back pain!


The current VA/DoD guidelines clearly state, “For patients who cannot tolerate a statin, we suggest a washout period followed by a rechallenge with the same or a different statin or lower dose, and if that fails, a trial of intermittent (nondaily) dosing”.

https://www.healthquality.va.gov/guidelines/CD/lipids/VADoDDyslipidemiaCPG5087212020.pdf (full disclosure and bias I helped write them)

N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects | NEJM was published in the NEJM and then a few weeks later Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials (bmj.com) was published in the BMJ.

Around that same time a publication in JAMA https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2773490 showed that using pharmacogenetic testing resulted in no worse LDL levels (soft endpoint) at one year but also no better


Episoder(386)

67. HPV, BPH, CTA and I'm ACB

67. HPV, BPH, CTA and I'm ACB

Yes! I am Andrew Christopher Buelt and in this all abbreviation and intial podcast I break down some recent studies that might are of interst. First, is HPV testing alone good enough? Should you do a ...

3 Apr 201820min

66. Zika, Concussion, Hip Surgery, New Guidelines

66. Zika, Concussion, Hip Surgery, New Guidelines

Is Zika as scary as we really think, or is it scarier?! There is a new test for concussion, right? You might wait a day for a hip surgery but don't wait two! Finally, This podcast is sweet but the new...

21 Mar 201819min

65. A Poor Prognosis of PE, UTI, Smoking

65. A Poor Prognosis of PE, UTI, Smoking

Andrew covers four articles that give a POOR PHYSICIAN PROGNOSIS for the rates of PE, the push for no-antibiotic-UTI, and smoking.

10 Mar 201819min

61. Joe Is Back To Discuss Three Articles

61. Joe Is Back To Discuss Three Articles

Guess who is back?! Joe joins me on QM and we talk about three recent trials give our thoughts and opinions while we both sip on a Diet Dr. Pepper. It is a quick 20 minutes of us talking out what we a...

4 Feb 201821min

60. New Format for Questioning Medicine

60. New Format for Questioning Medicine

Turns out when people say, 'You couldn't pay me enough money to quit smoking!' What they meant was "Can you please give me $750?" Kay-x still isn't great. I give my two cents on the hypertension guide...

1 Feb 201823min

59. DNR Listening to What You Should Watch

59. DNR Listening to What You Should Watch

How good are you at the DNR conversation? It is a conversation we all need to have with our patients no matter the field or specialty of medicine. However, it's a conversation we all avoid like the pl...

8 Des 201713min

58. Who pays when they leave AMA?

58. Who pays when they leave AMA?

Does insurance pay? Does the patient pay? What do you think? What do most Doctors think? Is it possible for me to write this entire description in only question form?

1 Des 20178min

57. Triple Therapy for AFIB After PCI, Trick or Treat?

57. Triple Therapy for AFIB After PCI, Trick or Treat?

We need to thin out the blood. Afib then to PCI and boom triple therapy. However, I suspect times are changing. It is Halloween and I do my best to play future fortune teller and predict the future in...

1 Nov 201725min

Populært innen Helse

fastlegen
lydartikler-fra-aftenposten
rss-gukild-johaug
hvordan-har-du-det-mann
psykodrama
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-garne-damer
hormonelle-frida
foreldreradet
morten-ramm-lar-kakla-ga-til-du-sovner
hjernesterk
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
rss-lopedrommen
klimaks
g-punktet
rss-kunsten-a-leve
treningsprat
rss-kull
helsetipspodden